NCT06144801 is a NA clinical trial of CoolSense Group in Hemolysis, sponsored by Karadeniz Technical University.

Who is sponsoring NCT06144801?

NCT06144801 is sponsored by Karadeniz Technical University.

What drugs are being tested in NCT06144801?

Interventions in NCT06144801: CoolSense Group.

What condition does NCT06144801 study?

NCT06144801 studies Hemolysis, Complementary Therapy, Pain, Comfort.

Is NCT06144801 still recruiting?

NCT06144801 is currently completed. Last updated 22 November 2023.

Last reviewed 2023-11-22 · How we verify

NCT06144801

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Coolsense Method on Pain and Comfort in Hemodialysis Patients

Completed NA Last updated 22 November 2023

What this trial tests

NA trial testing CoolSense Group in Hemolysis in 50 participants. Completed in 20 August 2023.

Timeline

20 February 2023

Primary endpoint
31 July 2023

20 August 2023

Quick facts

Lead sponsor	Karadeniz Technical University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	50
Start date	20 February 2023
Primary completion	31 July 2023
Estimated completion	20 August 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

CoolSense Group

Conditions studied

Hemolysis — all drugs for Hemolysis →
Complementary Therapy — all drugs for Complementary Therapy →
Pain — all drugs for Pain →
Comfort — all drugs for Comfort →

Sponsor

Karadeniz Technical University

Who can join

Adults 18 to 85, any sex, with Hemolysis or Complementary Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to investigate the impact of the CoolSense method on arteriovenous fistula cannulation pain and the comfort levels of hemodialysis patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The effect of using a local skin cooling device on arteriovenous fistula cannulation pain and comfort level of patients on hemodialysis: A single-blind randomized controlled study.
Demırağ H, Kulakaç N. · · 2025 · cited 2× · PMID 39467833 · DOI 10.1111/hdi.13190

Verify or expand the search:

Other recruiting trials for Hemolysis

Currently open trials in the same condition.

NCT07345091 — Feasibility Performance Study of ABL90 FLEX PLUS HEM · recruiting
NCT06721455 — Modeling Blood Management and Hemolytic Risk in Pediatric Heart Surgery · recruiting
NCT06861816 — Ventilatory Functions and Physical Intolerance in ESRD Adolescents: Response to Program of Walking With Dogs · NA · recruiting
NCT06806891 — Restless Leg Syndrome: Is There a Response to Buddhist Walking Meditation in Hemodialysis · NA · recruiting

Other Karadeniz Technical University trials

Trials by the same sponsor.

NCT07526779 — Motivational Interviewing on Loneliness Level, Activities of Daily Living, and Quality of Life in Elderly · NA · not yet recruiting
NCT07448168 — Effect of Standardized Patient Simulation on Nursing Students' Assessment, Diagnosis Skills, and Experiences · NA · not yet recruiting
NCT07435233 — Different Reality Simulation Education Methods on Nursing Students · NA · active not recruiting
NCT07238348 — Analgesic Effectiveness of SPSIPB Versus Thoracic Epidural and Systemic Opioid Analgesia After VATS (SPSIPB-VATS) · not yet recruiting
NCT07297498 — The Effect of Simulation-based Education Within the Framework of the Clinical Judgment Model on Nursing Students' Clinic · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06144801 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Karadeniz Technical University
Last refreshed: 22 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06144801.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing